Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Bacterial strains isolated from Japanese cancer patients treated with immune checkpoint inhibitors

PROVIDER: PRJDB17635 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	DRR628564_subreads.fastq.gz	Fastqsanger.gz
	DRR628565_subreads.fastq.gz	Fastqsanger.gz

Items per page:

1 - 3 of 3

Similar Datasets

human gut metagenome

Project description:Microbiome study of Japanese cancer patients treated with immune checkpoint inhibitors

| PRJDB17628 | ENA

Tsur2019 - Response of patients with melanoma to immune checkpoint blockade

Project description:This is a simple mathematical population model for pembrolizumab-treated advanced melanoma patients, used to predict the response of melanoma patients to immune checkpoint inhibitors.

2024-09-02 | BIOMD0000000838 | BioModels

Plasma proteomic profiles of SCLC patients treated with ICIs combined with anti-angiogenic therapy as second- or further-line treatment

Project description:Plasma proteomic profiles of small cell lung cancer patients treated with immune checkpoint inhibitors combined with anti-angiogenic therapy as second- or further-line treatment

2025-02-25 | PXD061159 |

LncRNA Expression Profiling in Renal Cancer Tissues

Project description:This study investigates the expression profiles of LncRNA in renal cancer tissues from patients treated with immune checkpoint inhibitors.

2024-09-04 | GSE276355 | GEO

Pre-treatment Molecular Characterizations of Tumors from Patients Who Receive Immune Checkpoint Therapies

Project description:<p>Immune checkpoint inhibitors yield clinical benefit in many cancer types, but molecular predictors of response have not yet been robustly characterized. In this study, we pursued whole exome sequencing (WES) of pre-treatment tumors from patients treated with immune checkpoint therapies - including monoclonal antibodies targeting programmed cell death-1 (PD-1) and cytotoxic T-lymphocyte-associated protein-4 (CTLA-4). Using these data, we aim to apply computational pipelines for mutation-calling, neoantigen prediction, and other analyses to validate pre-existing hypotheses regarding response to immune checkpoint therapies and discover new relationships with greater power. Further, by pursuing genomic characterization of tumors from patients with a variety of cancer types, we hope to describe molecular features of intrinsically sensitive or resistant tumors that are both context-specific and shared across cancer types.</p>

| phs001565 | dbGaP

Comparative cardiac transcriptomics of immune checkpoint inhibitor induced myocarditis

Project description:Immune checkpoint inhibitors (ICIs) are improving cancer treatments strikingly. The raising use leads to the augmented occurrence of immune related events. Myocarditis is a rare, but severe form of these adverse events. Nine patients with proven ICI induced myocarditis were subjected to myocardial biopsy. The tissue was used for RNA-seq analyses.

2020-11-01 | E-MTAB-8867 | biostudies-arrayexpress

DNA Methylation Inhibitors in Immunotherapy

Project description:<p>We show that DNA methyltransferase inhibitors (DNMTis) upregulate immune signaling in cancer through the viral defense pathway and re-expression of epigenetically silenced endogenous retrovirus. In melanoma patients treated with an immune checkpoint therapy, high viral defense signature expression in tumors significantly associates with durable clinical response and DNMTi treatment sensitizes to anti-CTLA4 therapy in a pre-clinical melanoma model.</p>

| phs001038 | dbGaP

Defining T cell states associated with response to checkpoint immunotherapy in melanoma

Project description:we profiled 16,291 immune cells from 48 tumor samples of melanoma patients treated with checkpoint inhibitors, using single-cell transcriptomics.

2018-10-05 | GSE120575 | GEO

Multiomics analysis of immune-related adverse events in melanoma patients treated with immune checkpoint inhibitors

Project description:Multiomics analysis of immune-related adverse events in melanoma patients treated with immune checkpoint inhibitors

| PRJNA942629 | ENA

Proteomics of heart of adult mice

Project description:Proteomics of heart of mouse which is treated with Immune checkpoint inhibitors

2022-02-16 | PXD031720 |